Approval · Notice of Compliance 26165 · 2021
DORMAZOLAM: Notice of Compliance 26165
Issued June 29, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26165
- Date
- June 29, 2021
- Company
- Dechra Regulatory BvBladel, Netherlands
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DORMAZOLAM | 02517582 | Marketed |
Medicinal ingredients
- MIDAZOLAM 5 MG per ML